Questions About the 2023 Infective Endocarditis Updated Criteria
- PMID: 38285912
- DOI: 10.1093/cid/ciae029
Questions About the 2023 Infective Endocarditis Updated Criteria
Conflict of interest statement
Potential conflicts of interest. W. E. A. was a site Principal Investigator for Disrupt, a Staphylococcus aureus bacteremia phase III clinical trial sponsored by Contrafect 2022. K. V. reports no potential conflicts. Both authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Comment on
-
Reply to Villareal and El-Altrouni: Clarifications of the 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis.Clin Infect Dis. 2024 Nov 22;79(5):1316-1318. doi: 10.1093/cid/ciae032. Clin Infect Dis. 2024. PMID: 38285901 Free PMC article. No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
